logo
logo
Sign in

Peptide Synthesis Market - Major Leaders & Their Global Dominance

avatar
Makarand Vaidya

Market growth can be attributed to increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers.

The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023.

Restraint:
Lack of a unified set of regulations for therapeutic peptides

Opportunity:
Emerging markets in the Asia Pacific region.

Challenges:
Issues associated with the route of administration of peptide drugs

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365

GenScript Biotech Corporation:

GenScript accounted for the largest share of the market in 2017. The company has a broad product/services portfolio in peptide synthesis market and focuses on research and development activities to enhance its offerings. For Instance, in 2016 the company’s research and development expenses were approximately USD 9.5 million, 8.3% of the total revenue. 

Major Market Developments:

In 2018, CEM Corporation launched the Liberty PRIME, automated microwave peptide synthesizer.

In 2017, Merck acquired Grzybowski Scientific Inventions (GSI) (US). This acquisition helped the company to expand its chemical synthesis portfolio.

In 2015, Merck acquired Sigma-Aldrich Corporation (US). This acquisition strengthened Merck’s Life Science segment. Sigma-Aldrich’s SAFC Commercial business is now a part of Merck’s Life Science segment.

Merck KGAA:

Merck held the second position in the peptide synthesis market in 2017. The company offers a broad product portfolio of peptide synthesis reagents and custom peptide synthesis services in the market. To leverage growth opportunities in the peptide synthesis market, Merck focuses on adopting organic as well as inorganic growth strategies. For instance, in 2017, the company opened a new Life Science Center in Burlington, Massachusetts (US).

Target Audience:

Biotechnology & pharmaceutical companies
Market research and consulting firms
Venture capitalists and investors
Research & development companies
Contract research organizations (CROs)
Academic research institutes|
Government institutes

Bachem holdings:

Bachem is an important player in the peptide synthesis market in 2017. The company offers catalog products that include amino acids, resins, linkers, & reagents. It also offers custom synthesis services in the market. The company aims on broadening its geographic reach by investing in strategic acquisitions, agreements, and collaborations. For instance in 2017, the company has renewed its supply agreement with AstraZeneca for the peptide active substance Goserelin. 

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365

APAC is expected to grow at the highest CAGR during the forecast period.

Global peptide synthesis market has been studied for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in the peptide synthesis market, primarily due to the increasing investments by pharmaceutical and biotechnology companies and rising R&D activities in the region.

Product launches and agreements, partnerships and collaborations were the major strategies adopted by these payers to maintain their positions in the peptide synthesis market. 

collect
0
avatar
Makarand Vaidya
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more